The findings show that estrogen signaling, especially via estrogen receptor beta (ERβ), contributes to oncogenesis, and that incorporating sex-specific risk assessment, hormonal level modification, and targeted gene therapies into clinical practice may improve screening and outcomes for females with lung adenocarcinoma...
M. Virata, Rizal Michael R. Abello, E. Brillante et al.· Oncology Reviews· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.